dokumendiregister.ee
OtsingAsutusedMCP
Otsing›Terviseamet
Sissetulev dokumentAvalik

Infokiri

Terviseamet · 6. märts 2025
Viit
8-2/25/1661-1
Registreeritud
6. märts 2025
Dokumendi liik
Sissetulev dokument
Adressaat
EURO Influenza
Saabumis/saatmisviis
e-post
Funktsioon
8 Nakkushaiguste seire, ennetuse ja tõrje korraldamine
Sari
8-2 Nakkushaiguste epidemioloogiaalane riigiväline kirjavahetus
Toimik
8-2/2025
Vastutaja
Kärt Sõber (TA, Peadirektori asetäitja (1) vastutusvaldkond, Nakkushaiguste epidemioloogia osakond)

Failid

  • 📎E-kiri.eml45 KB

Sisu (failidest)

Saatja: "EURO Influenza" <[email protected]> Saaja: "EURO Influenza" <[email protected]> Teema: Fw: [gisrs] Recommended composition of influenza virus vaccines for use in the 2025-2026 northern hemisphere influenza season - update Kuupäev: 2025-03-05 14:59 Далее следует текст на русском языке / This message follows in Russian Dear colleagues, In February 2025 the World Health Organization has convened the technical consultation on the viral composition of influenza vaccines for the 2025-2026 influenza season in the northern hemisphere. These consultations are organized by WHO twice a year, in February and September, with an advisory group of experts from WHO Collaborating Centres, H5 Reference Laboratories and Essential Regulatory Laboratories to review available characterization data of circulating influenza viruses generated by the WHO Global Influenza Surveillance and Response System (GISRS) and make recommendations on the viruses to be included in the tri- and quadrivalent vaccines for the use during the next influenza season in Northern and Southern hemispheres, respectively. As an outcome of this consultation the WHO has announced the Recommended composition of influenza virus vaccines for use in the 2025-2026 northern hemisphere influenza season ( <https://www.who.int/publications/m/item/recommended-composition-of-influe nza-virus-vaccines-for-use-in-the-2025-2026-nh-influenza-season> https://www.who.int/publications/m/item/recommended-composition-of-influen za-virus-vaccines-for-use-in-the-2025-2026-nh-influenza-season). Please see below links to this and other resources published on the WHO webpage and shared by the WHO Global Influenza Programme. We would like to thank you all for your great contributions and collaboration! Best regards, The WHO/EURO Influenza and Respiratory Viruses team Далее следует текст на русском языке / This message follows in Russian Уважаемые коллеги, В феврале 2025 года Всемирная организация здравоохранения созвала техническую консультацию по штаммовому составу вакцин против сезонного гриппа на эпидемический сезон 2025-2026 гг. в северном полушарии. Эти консультации организуются ВОЗ два раза в год, в феврале и сентябре, с участием консультативной группы экспертов из сотрудничающих центров ВОЗ, референс лабораторий по гриппу H5 и головных контрольных лабораторий для рассмотрения имеющихся данных о характеристиках циркулирующих вирусов гриппа, полученных Глобальной системой ВОЗ по эпиднадзору за гриппом и принятию ответных мер (ГСЭГО) и предоставления рекомендации по вирусам, которые должны быть включены в трех- и четырехвалентные вакцины для использования в следующем сезоне гриппа в Северном и Южном полушариях соответственно. По итогам этой консультации ВОЗ объявила рекомендации по вирусному составу вакцин против гриппа на сезон гриппа 2025-2026 гг. в северном полушарии ( <https://www.who.int/publications/m/item/recommended-composition-of-influe nza-virus-vaccines-for-use-in-the-2025-2026-nh-influenza-season> https://www.who.int/publications/m/item/recommended-composition-of-influen za-virus-vaccines-for-use-in-the-2025-2026-nh-influenza-season на английском языке). Ниже приведены ссылки на этот и другие ресурсы, опубликованные на веб-странице ВОЗ и предоставленные Глобальной программой ВОЗ по гриппу. Мы хотели бы поблагодарить всех вас за ваш вклад и сотрудничество! С уважением, Команда ЕРБ ВОЗ по гриппу и респираторным вирусам From: GISRS Information Centre <[email protected]> Sent: Tuesday, March 4, 2025 9:04 PM To: GISRS Information Centre <[email protected]> Subject: [EXT] [gisrs] Recommended composition of influenza virus vaccines for use in the 2025-2026 northern hemisphere influenza season - update Dear GISRS colleagues, Thank you for your extensive contribution to the GISRS surveillance. We would like to bring your attention to the Influenza Vaccines Composition Consultation Meeting (VCM) documents on the WHO website: Recommended composition of influenza virus vaccines for use in the 2025-2026 northern hemisphere influenza season ( <https://www.who.int/publications/m/item/recommended-composition-of-influe nza-virus-vaccines-for-use-in-the-2025-2026-nh-influenza-season> https://www.who.int/publications/m/item/recommended-composition-of-influen za-virus-vaccines-for-use-in-the-2025-2026-nh-influenza-season) Antigenic and genetic characteristics of zoonotic influenza A viruses and development of candidate vaccine viruses for pandemic preparedness in the 2025 - 2026 northern hemisphere influenza season ( <https://cdn.who.int/media/docs/default-source/influenza/who-influenza-rec ommendations/vcm-northern-hemisphere-recommendation-2025-2026/202502_zoono tic_vaccinvirusupdate.pdf?sfvrsn=b7ee9689_5> https://cdn.who.int/media/docs/default-source/influenza/who-influenza-reco mmendations/vcm-northern-hemisphere-recommendation-2025-2026/202502_zoonot ic_vaccinvirusupdate.pdf?sfvrsn=b7ee9689_5) Frequently Asked Questions - Recommended composition of influenza virus vaccines <https://cdn.who.int/media/docs/default-source/influenza/who-influenza-rec ommendations/vcm-northern-hemisphere-recommendation-2025-2026/202502_frequ ently-asked-questions.pdf?sfvrsn=8011210d_5> https://cdn.who.int/media/docs/default-source/influenza/who-influenza-reco mmendations/vcm-northern-hemisphere-recommendation-2025-2026/202502_freque ntly-asked-questions.pdf?sfvrsn=8011210d_5) Seasonal influenza candidate vaccine viruses and potency testing reagents for development and production of vaccines ( <https://www.who.int/teams/global-influenza-programme/vaccines/who-recomme ndations/candidate-vaccine-viruses> https://www.who.int/teams/global-influenza-programme/vaccines/who-recommen dations/candidate-vaccine-viruses) Zoonotic influenza candidate vaccine viruses and potency testing reagents for development and production of vaccines: ( <https://www.who.int/teams/global-influenza-programme/vaccines/who-recomme ndations/zoonotic-influenza-viruses-and-candidate-vaccine-viruses> https://www.who.int/teams/global-influenza-programme/vaccines/who-recommen dations/zoonotic-influenza-viruses-and-candidate-vaccine-viruses) Those of you who could not join the VCM information meeting live, could access the recording on the WHO YouTube channel: VCM Information meeting: <https://www.youtube.com/watch?v=kGTmLmiBL-Y> https://www.youtube.com/watch?v=kGTmLmiBL-Y VCM Press conference: <https://www.youtube.com/watch?v=OCqbYb4NxOo> https://www.youtube.com/watch?v=OCqbYb4NxOo Thank you all for your great contribution and collaboration. Best regards, On behalf of the WHO Global Influenza Programme
Allikas: Terviseamet dokumendiregister →
dokumendiregister.eeAsutusedEesti avalike dokumendiregistrite otsing · nimistu.ee andmetel